PHO · NASDAQ

Invesco Water Resources ETF (PHO)

$72.71
Pre-market+2.28 (+3.24%)
At close$70.43(+0.44%)
  1. Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

    GuruFocus

    Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II PR N

  2. Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced that the U.S. Food and Drug Administration (FDA) has published a proposed

  3. Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced that the U.S. Food and Drug Administration (FDA) has published a proposed

  4. Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?

    Zacks Investment Research

    The Invesco Water Resources ETF (PHO) was launched on 12/06/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Industrials ETFs category of the market.

  5. Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

    GuruFocus

    Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S. PR Newswire

  6. Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated

  7. Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the 'Healthcare Resource Utilization and Costs Associated

  8. Should You Invest in the Invesco Water Resources ETF (PHO)?

    Zacks Investment Research

    Looking for broad exposure to the Industrials - Water segment of the equity market? You should consider the Invesco Water Resources ETF (PHO), a passively managed exchange traded fund launched on December 6, 2005.

  9. Photocure ASA: Results for the second quarter of 2026

    GuruFocus

    Photocure ASA: Results for the second quarter of 2026 PR Newswire OSLO, Norway, July 29, 2026

  10. Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?

    Zacks Investment Research

    Making its debut on 12/06/2005, smart beta exchange traded fund Invesco Water Resources ETF (PHO) provides investors broad exposure to the Industrials ETFs category of the market.

  11. Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research

  12. Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research

  13. Should You Invest in the Invesco Water Resources ETF (PHO)?

    Zacks Investment Research

    Looking for broad exposure to the Industrials - Water segment of the equity market? You should consider the Invesco Water Resources ETF (PHO), a passively managed exchange traded fund launched on December 6, 2005.

  14. Photocure ASA: Results for the first quarter of 2026

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix/Cysview revenues of NOK 139.0 million in the first quarter of 2026 (Q1 2025: NOK 125.3

  15. New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication in 'The Journal of Medical Economics' of a novel health

  16. New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication in 'The Journal of Medical Economics' of a novel health

  17. Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?

    Zacks Investment Research

    The Invesco Water Resources ETF (PHO) was launched on 12/06/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Industrials ETFs category of the market.

  18. Should You Invest in the Invesco Water Resources ETF (PHO)?

    Zacks Investment Research

    Launched on December 6, 2005, the Invesco Water Resources ETF (PHO) is a passively managed exchange traded fund designed to provide a broad exposure to the Industrials - Water segment of the equity market.

  19. Invesco Water Resources ETF (NASDAQ:PHO) Stock Crosses Below Fifty Day Moving Average – Should You Sell?

    Defense World

    Invesco Water Resources ETF (NASDAQ: PHO - Get Free Report) shares passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $72.01 and traded as low as $65.87. Invesco Water Resources ETF shares last traded at $66.53, with a volume of 76,520 shares. Invesco Water

  20. Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway

    PRNewsWire

    /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of